February 28, 2011Date Released: 9 May 2014
CASE CCC IN THE NEWS
Cleveland Clinic Researchers Hopeful About Study Findings, Promise of Future Prostate Cancer Test
MARK YOUR CALENDARSCancer Center Seminar Series: Retinoids and Cancer
Friday, March 4
Please join us Friday, March 4 at the next Cancer Center Seminar Series featuring Noa Noy, PhD. Dr. Noy, Professor of Pharmacology, will present Retinoids and Cancer.
Dr. Noy has had a long-standing interest in understanding the physiological functions and mechanisms of action and of nuclear hormone receptors, especially as related to receptors that respond to retinoids (vitamin A and its metabolites). Her laboratory discovered that the transcriptional activities of retinoic acid (RA) are mediated by two different nuclear receptors, RAR and PPARβ/δ. Furthermore, the group found that RA signaling partitions between these pathways through the actions of two binding proteins: CRABP-II, which delivers RA to RARs, and FABP5, which shuttles the hormone to the alternate receptor PPARβ/δ. The laboratory showed that dysregulation of the balance between these two pathways underlies the RA-resistance of some cancers. On-going work aims to develop novel anticarcinogenic agents that will inhibit mammary carcinoma growth by restoring proper RA signaling. Recently, the Noy laboratory established that the parental vitamin A molecule, retinol, which has long been believed to function solely through active metabolites, is in fact a signaling molecule in its own right, which can regulate gene transcription through the JAK/STAT cascade. These observations indicate the scope of the biological activities of vitamin A is broader than previously suspected.Cancer Imaging Program Cellular Imaging Focus Group "Mini Talk"
The leaders of the Cancer Imaging Program invite you to attend a Cellular Imaging Focus Group "Mini Talk", Monday, February 28 at 3:30 pm in Wearn B-37. Drs. David Wilson, Zhenghong Lee and Alex Huang are featured presenters. All are welcome and encouraged to attend. Please contact Drs. Zhenghong Lee (firstname.lastname@example.org) or James Basilion (email@example.com) for more information.Case CCC Scientific Series
The next installment of the Case CCC Scientific Series is scheduled for Thursday, April 21 from 4-6:30 pm in Wolstein Auditorium (WRB 1-413). Drs. Anton Gorbachev, Neetu Gupta and Alex Huang will discuss the topic of Immunology. Presentations will be followed by a short receptions. All are encouraged to attend.CWRU Research Best Practices Day
Registration is open for the CWRU Research Best Practices Day, Friday, March 18 from 8 am - 2 pm in Wolstein Auditorium (WRB 1-413). Planned sessions include Responsible Conduct of Research, Conflicts of Interests in Research, Technology Transfer, Human Subjects Protections, and Research Financials. Investigators, study coordinators, department assistants, graduate students and others involved in research at CWRU and the affiliated hospitals are encouraged to attend.Case CCC Annual Scientific Retreat
The Case CCC Annual Scientific Retreat will be July 8-9 at Corporate College East. Details will be posted soon.
FUNDING OPPORTUNITIESAmerican Cancer Society Research Scholar Grants
With a primary focus on beginning investigators, the ACS Extramural Grants Program seeks to support and promote high impact and innovative cancer research across a wide range of disciplines to meet critically important needs in the control of cancer. Each year, the Society receives approximately 2,000 requests for research funding and health care professional training support. All proposals are subjected to multiple levels of peer review to identify the most meritorious and innovative projects for funding. The Society offers extramural support for research and training via five programs: Health Professional Training in Grant Control, Molecular Genetics and Biochemistry of Cancer, Cancer Cell Biology and Metastasis, Preclinical and Translational Cancer Research, Clinical Cancer Research and Immunology, and Cancer Control and Prevention Research.
Applications are being accepted for ACS Research Scholar Grants, which provide the resources for investigator-initiated research in a variety of cancer-relevant areas. Applicants must be independent, self-directed researchers within six years of their first academic appointment.
Applicants to the ACS Cancer Control and Prevention Research Program ONLY may be at any career stage provided the focus of their project is either: 1) health policy/health services research or 2) cancer disparity reduction.
Deadline: April 1
NCI CANCER BULLETINFebruary 22, 2011
**All events are open to anyone interested in attending
Pathology Research Seminar
Cancer Imaging Program Cellular Imaging Focus Group "Mini Talk"
Physiology and Biophysics Seminar
Cancer Center Postdoctoral Candidate Seminar
Cancer Biology Seminar
Immunology Seminar: Aikawa Lecture
Department of Medicine Grand Rounds
Taussig Cancer Institute Core Curriculum Series
Hematology and Oncology Division Research Conference
2010 Science Nobel Prizes: What Were They Given For?
Taussig Cancer Institute Grand Rounds
Cancer Center Seminar Series
Cancer Center Research in Progress Seminar
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Breast Cancer Detection and Management: Issues for 2011
Case CCC Annual Scientific Retreat
ADDITIONAL UPCOMING SEMINARS & EVENTS
Multilevel Interventions in Health Care: Building the Foundation for Future Research Goals
4th Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science
Fourth Annual Translational to Clinical (T2C) Wound Care Conference
Midwest Blood Club 9th Annual Symposium
2011 Clinical and Translational Research and Education Meeting: ACRT/SCTS Joint Annual Meeting
Cincinnati Cancer Symposium Series: 2011 Symposium on NF-κB, Cancer, Obesity, and Inflammation
4th International Symposium on Cancer Metastasis and the Lymphovascular System
International Society for Stem Cell Research (ISSCR) Annual Meeting
Cancer Health Disparities Summit 2011
8th International Conference of the Society for Integrative Oncology
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Prevent Cancer Foundation
Avon Foundation Breast Cancer Research Program
NIH BULLETIN – Notices and Funding Opportunities
Testing Tobacco Products Promoted to Reduce Harm (R21) (PA-09-047)
Correlative Studies with Specimens from Multi-Site Trials (R01) (PA-08-134)
Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) (PA-08-267)
Public Comment Period Open on Proposed Adoption and Implementation of the Guide for the Care and Use of Laboratory Animals: Eighth Edition (NOT-OD-11-042)
Reminder of Requirement for Certification Letter for Applications in Response to Kirschstein-NRSA for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research (PA-11-112) (NOT-OD-11-046)
Notice of Change in Policy on the Submission of Reference Forms (Letters of Reference) for Kirschstein-NRSA Fellowship (F) Applications (NOT-OD-11-047)
Announcing the Transition of Single Research Project Cooperative Agreements (Single Project U01s) to Electronic Submission for Due Dates on or After May 25, 2011 (NOT-OD-11-048)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.